UNSPSC 51191552: Hydroxindasate

This classification denotes a diuretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8687J667P. European Medicines Agency schedules Hydroxindasate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08072MIG. Hydroxindasate generally arises in the molecular formula C21H24N2O3. The term HYDROXINDASATE is an International Non-Proprietary Name or INN. HYDROXINDASATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule hydroxindasate under HS 29339990 and SITC 51577. As of Q4 2014, HYDROXINDASATE remains the US FDA Preferred Term for this commodity. Hydroxindasate bears US NLM identifiers UMLS ID C1881075 and NCI Concept Code C65866. SMILES: O(C1CC2C(C(N(C2CC1)CC1CCC(OC)CC1)C)CCN)C(=O)C.

UNSPSC 51191552 Hydroxindasate, a Commodity code, covers specialized chemical products and equipment used in municipal water and wastewater treatment, correctional healthcare delivery, and industrial process applications. State and local governments procure under this code infrequently and for narrowly defined operational needs: sodium bisulfite for municipal water pollution control; parenteral nutrition and intravenous solutions for correctional healthcare; and specialized valve components with SCADA integration for wastewater treatment compliance. The issuing bodies are primarily municipal water utilities, state correctional departments, and county environmental services agencies managing permit-driven treatment operations. These are typically single-use or ongoing supply contracts where the specified commodity or equivalent product meets strict regulatory or operational requirements, often with sole-source or limited-competition profiles.

Recent activity spans Florida, Washington, and Connecticut. Broward County, Florida issued a Request for Information in September 2026 (BLD6232026F23, due September 29) to explore multi-source alternatives to DeZurik/APCO valves and repair services currently provided exclusively by Controls Specialties, Inc., with emphasis on SCADA-compatible electric actuators and preventive maintenance capability for wastewater treatment compliance. The Washington State Department of Corrections issued an RFQ in September 2026 (RFQQK13020, due October 7) for parenteral products, services, and equipment—including parenteral nutrition, intravenous solutions, and controlled substances—to supply eight facilities across three regions with firm pricing through June 2030, targeting multiple awards (up to three per region) and encouraging small business (25%), minority-owned (10%), women-owned (6%), and veteran-owned (5%) participation under Chapter 39.19 RCW. The City of Meriden, Connecticut solicited bids for sodium bisulfite chemical supply in August 2026 (B027-15, due July 29) for its Water Pollution Control Facility under a standard municipal IFB structure with performance and payment bond requirements.